For research and educational purposes only. Not medical advice.
Tianeptine Reference
Educational, not medical advice reference for Tianeptine: Nootropic; regulatory status, evidence posture, source review, and schedule notes. Also known as St…
Reference summary
European antidepressant literature is positive at therapeutic doses. Abuse / dependence at supratherapeutic doses (5-10× labeled) is extensively documented in US poison-center and case-report literature.
- Categories
- Nootropic
- Aliases
- Stablon, Coaxil, Tatinol
- Evidence posture
- human — Not FDA-approved. Schedule II in multiple US states. FDA has issued explicit consumer warnings against 'gas station heroin' tianeptine products. Abuse and dependence at supratherapeutic doses are extensively documented; cold turkey produces severe opioid-like withdrawal.
- Regulatory status
- No FDA-approved tianeptine drug label. Approved as an antidepressant in France, some EU and Latin American countries, and former-Soviet states. Schedule II in several US states (Alabama, Indiana, Kentucky, Michigan, Minnesota, Mississippi, Ohio, Tennessee, Florida) due to abuse potential. FDA has issued multiple consumer warnings against tianeptine 'gas station heroin' products.
- Content review status
- research reference